CVS HEALTH CORPORATION REPORTS STRONG SECOND QUARTER 2026 RESULTS AND RAISES FULL-YEAR 2026 GUIDANCE

Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58 Generated year-to-date cash flow from operations of $10.6 billion Raising full-year 2026 guidance: GAAP diluted EPS guidance range to $6.84...